Open Label, Phase I Study to Assess and Compare the Pharmacokinetic Parameters After Single Oral Administration of MD1003 100 mg in Renal Impaired Patients and Healthy Subjects With Normal Renal Function
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Biotin (Primary)
- Indications Adrenoleucodystrophy; Adrenomyeloneuropathy; Amyotrophic lateral sclerosis; Charcot-Marie-Tooth disease; Chronic inflammatory demyelinating polyradiculoneuropathy; Encephalomyelitis; Multiple sclerosis
- Focus Therapeutic Use
- Sponsors MedDay Pharmaceuticals
- 19 May 2020 New trial record